Compare Aurobindo Pharma with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ASTRAZENECA PHARMA - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ASTRAZENECA PHARMA AUROBINDO PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 19.6 129.8 15.1% View Chart
P/BV x 4.2 36.5 11.6% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 AUROBINDO PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
ASTRAZENECA PHARMA
Mar-18
AUROBINDO PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs8301,278 64.9%   
Low Rs527883 59.7%   
Sales per share (Unadj.) Rs333.9228.4 146.2%  
Earnings per share (Unadj.) Rs40.410.4 389.4%  
Cash flow per share (Unadj.) Rs51.816.3 318.3%  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs237.198.8 240.0%  
Shares outstanding (eoy) m585.9125.00 2,343.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.04.7 43.0%   
Avg P/E ratio x16.8104.2 16.1%  
P/CF ratio (eoy) x13.166.4 19.7%  
Price / Book Value ratio x2.910.9 26.2%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m397,56927,008 1,472.1%   
No. of employees `00017.91.4 1,316.7%   
Total wages/salary Rs m25,8491,535 1,683.6%   
Avg. sales/employee Rs Th10,956.94,210.9 260.2%   
Avg. wages/employee Rs Th1,447.71,132.2 127.9%   
Avg. net profit/employee Rs Th1,324.3191.1 693.1%   
INCOME DATA
Net Sales Rs m195,6365,710 3,426.2%  
Other income Rs m1,553123 1,267.9%   
Total revenues Rs m197,1895,833 3,380.9%   
Gross profit Rs m39,519463 8,537.4%  
Depreciation Rs m6,680147 4,531.5%   
Interest Rs m2,6260-   
Profit before tax Rs m31,767438 7,252.8%   
Minority Interest Rs m270-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269179 4,062.9%   
Profit after tax Rs m23,645259 9,125.8%  
Gross profit margin %20.28.1 249.2%  
Effective tax rate %22.940.8 56.0%   
Net profit margin %12.14.5 266.4%  
BALANCE SHEET DATA
Current assets Rs m153,6453,209 4,787.6%   
Current liabilities Rs m120,4292,070 5,819.2%   
Net working cap to sales %17.020.0 85.1%  
Current ratio x1.31.6 82.3%  
Inventory Days Days13572 186.9%  
Debtors Days Days6435 182.4%  
Net fixed assets Rs m103,909790 13,148.0%   
Share capital Rs m58650 1,171.8%   
"Free" reserves Rs m138,3222,419 5,717.4%   
Net worth Rs m138,9082,469 5,625.4%   
Long term debt Rs m1,8000-   
Total assets Rs m264,5444,605 5,744.2%  
Interest coverage x13.1NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.71.2 59.6%   
Return on assets %9.95.6 176.5%  
Return on equity %17.010.5 162.2%  
Return on capital %23.817.7 134.4%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Exports (fob) Rs m97,091NA-   
Imports (cif) Rs m36,741NA-   
Fx inflow Rs m97,316300 32,487.5%   
Fx outflow Rs m40,5892,015 2,014.4%   
Net fx Rs m56,727-1,715 -3,307.0%   
CASH FLOW
From Operations Rs m16,22088 18,453.1%  
From Investments Rs m-28,768-94 30,735.4%  
From Financial Activity Rs m19,191NA-  
Net Cashflow Rs m6,656-6 -116,778.9%  

Share Holding

Indian Promoters % 54.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 8.0 0.3 2,650.0%  
FIIs % 27.7 15.7 176.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.2 9.1 112.1%  
Shareholders   69,601 12,856 541.4%  
Pledged promoter(s) holding % 8.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare AUROBINDO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; Dow Futures Up by 90 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 34 points, up 0.1% at 48,844 levels.

Related Views on News

J.B.CHEMICALS Share Price Up by 7%; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

J.B.CHEMICALS share price is trading up by 7% and its current market price is Rs 1,066. The BSE HEALTHCARE is up by 1.0%. The top gainers in the BSE HEALTHCARE Index are J.B.CHEMICALS (up 7.2%) and AUROBINDO PHARMA (up 8.0%). The top losers are DR. LAL PATHLABS (down 0.2%) and CAPLIN POINT (down 0.3%).

AUROBINDO PHARMA Share Price Up by 10%; BSE HEALTHCARE Index Up 1.4% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

AUROBINDO PHARMA share price is trading up by 10% and its current market price is Rs 1,021. The BSE HEALTHCARE is up by 1.4%. The top gainers in the BSE HEALTHCARE Index is AUROBINDO PHARMA (up 10.3%). The top losers are NATCO PHARMA (down 0.3%) and ERIS LIFESCIENCES (down 0.4%).

CIPLA Share Price Up by 5%; BSE HEALTHCARE Index Up 1.2% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

CIPLA share price is trading up by 5% and its current market price is Rs 850. The BSE HEALTHCARE is up by 1.2%. The top gainers in the BSE HEALTHCARE Index are CIPLA (up 5.0%) and AUROBINDO PHARMA (up 9.6%). The top losers are NATCO PHARMA (down 0.2%) and PIRAMAL ENTERPRISES (down 0.6%).

AUROBINDO PHARMA at All Time High; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

AUROBINDO PHARMA share price has hit an all time high at Rs 1,012 (up 9.4%). The BSE HEALTHCARE Index is up by 1.0%. Among the top gainers in the BSE HEALTHCARE Index today are AUROBINDO PHARMA (up 9.4%) and ABBOTT INDIA (up 0.8%). The top losers include THYROCARE TECHNOLOGIES (down 0.1%) and LAURUS LABS (down 0.2%).

LAURUS LABS at 52 Week High; BSE 500 Index Down 0.2% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

LAURUS LABS share price has hit a 52-week high. It is presently trading at Rs 381. BSE 500 Index is down by 0.2% at 19,022. Within the BSE 500, LAURUS LABS (up 2.5%) and GATEWAY DISTRIPARKS (up 12.4%) are among the top gainers, while top losers are VODAFONE IDEA and APOLLO TYRES.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Jan 25, 2021 03:20 PM

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS